Joshua Tseng

Papers

Total Citations

H-Index

About

Joshua Tseng is a surgical oncologist whose research focuses on improving outcomes for patients with adrenocortical carcinoma (ACC), a rare and aggressive endocrine malignancy. His work has centered on optimizing surgical management, particularly through the evaluation of lymphadenectomy and the impact of operative approach and case volume on achieving negative resection margins—a critical factor in patient survival. In his landmark 2021 study, Tseng demonstrated the survival benefit of systematic lymph node dissection during ACC resection, a finding that has influenced surgical guidelines. His 2022 follow-up paper further established that high-volume centers and specific operative techniques significantly improve margin-negative resection rates. Collectively, these studies have garnered over 20 citations, underscoring their influence in the field. Tseng’s contributions are notable for translating complex surgical data into actionable clinical strategies, advancing the standard of care for a disease with historically poor prognosis. His work exemplifies the power of focused, high-impact research in rare cancers.